Monte Rosa Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $22M | 3.0M | 7.41 |
| 2025-06-30 | $14M | 3.1M | 4.51 |
| 2025-03-31 | $14M | 3.1M | 4.64 |
| 2024-12-31 | $22M | 3.2M | 6.94 |
| 2024-09-30 | $13M | 2.5M | 5.30 |
| 2024-06-30 | $9.5M | 2.5M | 3.74 |
| 2024-03-31 | $12M | 1.6M | 7.05 |
| 2023-12-31 | $9.0M | 1.6M | 5.65 |
| 2023-09-30 | $7.8M | 1.6M | 4.79 |
| 2023-06-30 | $11M | 1.6M | 6.85 |
| 2023-03-31 | $11M | 1.4M | 7.79 |
| 2022-12-31 | $11M | 1.4M | 7.61 |
| 2022-06-30 | $22M | 2.3M | 9.67 |
| 2022-03-31 | $42M | 3.0M | 14.02 |
| 2021-09-30 | $23M | 1.0M | 22.28 |
| 2021-06-30 | $2.3M | 100k | 22.54 |